Unichem Laboratories surges on getting approval for Zonisamide Capsules

28 Jan 2021 Evaluate

Unichem Laboratories is currently trading at Rs. 295.15, up by 6.10 points or 2.11% from its previous closing of Rs. 289.05 on the BSE.

The scrip opened at Rs. 289.95 and has touched a high and low of Rs. 298.95 and Rs. 287.40 respectively. So far 5178 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 304.20 on 04-Aug-2020 and a 52 week low of Rs. 75.10 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 301.15 and Rs. 283.10 respectively. The current market cap of the company is Rs. 2079.08 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.63% and 38.44% respectively.

Unichem Laboratories has received Abbreviated New Drug Application (ANDA) approval for its Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals Inc. Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

581.75 -3.75 (-0.64%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.